Pelthos Therapeutics Inc. /
LNHC
Pelthos Therapeutics completes merger with LNHC, Inc.
Source for the buyer and target: Pelthos Therapeutics Inc.
For the buyer and target.
“Pursuant to the Merger Agreement, (i) Merger Sub merged with and into LNHC, with LNHC as the surviving company in the merger and, after giving effect to such merger, continuing as a wholly-owned subsidiary of the Company (the “Merger”) and (ii) the Company’s name was changed from Channel Therapeutics Corporation (“Channel”) to Pelthos Therapeutics Inc. (the “Combined Company”).”
Published 16 Sep 2025
Open the sourceWhat happened
Pelthos Therapeutics Inc. completed its merger with LNHC, Inc. on July 1, 2025. LNHC survived the merger and continued as a wholly owned subsidiary of Pelthos Therapeutics Inc. [01]
LNHC provides development and manufacturing services for drug products developed using the NITRICIL platform technology. [01]
The source
Everything on this page comes from the source below, quoted word for word.
Pelthos Therapeutics completes merger with LNHC, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
Closed
“Pelthos Therapeutics completes merger with LNHC, Inc. Pelthos Therapeutics Inc. completed its merger with LNHC, Inc. on July 1, 2025”
Open the source
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly